Prostate Cancer
Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer.
November 25, 2024
PSMA Radiotheranostics in Prostate Cancer: Principles, Practice, and Future Prospects.
November 25, 2024
Association of Race and Area of Deprivation Index with Prostate Cancer Incidence and Lethality.
November 25, 2024
Cost-effectiveness analysis of additional local prostate radio therapy in metastatic prostate cancer from a medicare perspective.
November 25, 2024
Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation Therapy.
November 25, 2024
Integrated framework for quantitative T2-weighted MRI analysis following prostate cancer radiotherapy.
November 22, 2024
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer.
November 22, 2024
Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate Cancer.
November 22, 2024
Preoperative prostate magnetic resonance imaging does not impact surgical outcomes of radical prostatectomy.
November 21, 2024
Prostate Cancer Screening: Common Questions and Answers.
November 21, 2024